Reaction Details |
| Report a problem with these data |
Target | C-X-C chemokine receptor type 3 |
---|
Ligand | BDBM50595536 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2216909 (CHEMBL5130041) |
---|
IC50 | 68±n/a nM |
---|
Citation | Caroff, E; Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125. J Med Chem65:11533-11549 (2022) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
C-X-C chemokine receptor type 3 |
---|
Name: | C-X-C chemokine receptor type 3 |
Synonyms: | AAO92295.1 | C-X-C chemokine receptor type 3 | C-X-C chemokine receptor type 3 (CXCR3) | C-X-C chemokine receptor type 3 (CXCR3A) | CXCR3 | CXCR3A | CXCR3_HUMAN | GPR9 | chemokine (C-X-C motif) receptor 3 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 40665.65 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 368 |
Sequence: | MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALY
SLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFG
SGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCL
LFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILA
VLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAK
SVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSET
SEASYSGL
|
|
|
BDBM50595536 |
---|
n/a |
---|
Name | BDBM50595536 |
Synonyms: | CHEMBL5198121 |
Type | Small organic molecule |
Emp. Form. | C25H27F3N8O3S |
Mol. Mass. | 576.594 |
SMILES | C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1nc2ccc(OC3COC3)cc2[nH]1)C(F)(F)F |r| |
Structure |
|